+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-10-09Number of Pages: 158

Medical Polymers (Product - Medical Resins and Fibers (Polyvinyl Chloride (PVC), Polypropylene (PP), Polyethylene (PE), and Polystyrene (PS)), Medical Elastomers (Styrenic Block Copolymer (SBC) and Rubber Latex), and Biodegradable Plastics); Application - Medical Devices and Equipment and Medical Packaging) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Global Medical Polymers Market: Snapshot

Medical polymers is the collective term used for biodegradable plastic, elastomers such as thermoplastic elastomers and natural, and polymers such as fibers and resins which is employed in several forms in healthcare and medical applications. Generally, ceramics, glass, and metals have been employed as medical supports, devices, and implants. Nevertheless, polymers are considered to be more suitable for medical applications owing to low cost, better biocompatibility, and less weight. Medical polymers are mainly used in equipment and devices such as implants for cranial injuries, joint and hip replacement, and spinal implants. However, the implementation of strict regulations pertaining to the launch of new products along with fluctuating prices of raw materials may impede the growth of the market to some extent.

Over the next couple of years, the demand for medical polymers is likely to gain momentum. The demand for medical polymers is also expected to be fueled due to the mounting geriatric population and growing preference on home healthcare treatments. Ongoing development in the field of polymer science and increasing awareness among consumers are also likely to play a crucial role in the growth of the market. The global medical polymers market is likely to expand at an 8.3% CAGR from 2014 to 2020. It is anticipated to be worth US$17.13 bn by the end of 2020 from a valuation of US$9.80 bn in 2013.

Fiber and Resins to Emerge as Dominant Product Type

In 2013, fiber and resins surfaced as the leading product type with a share of over 85% in the global medical polymers market. The product type which is likely to witness the leading growth rate during the forecast period is biodegradable plastics. Growing need for materials that are biocompatible, especially in implants, is likely to propel the demand for biodegradable polymers in the coming years. Although fiber and resins lead the market at present, it is likely to lose its market shares along with elastomers to biodegradable polymers over the forecast period. The medical packaging and medical equipment and devices segments together held a share of 90% in the global market based on volume in 2013. The demand for medical procedures is likely to rise over time owing to lifestyle changes and growing health issues among people across the globe. The rise in surgical procedures is further expected to bode well for the growth of the market.

North America to Retain Lead with Enhanced Infrastructure

In 2013, North America emerged as the leading region with over 40% of the total share in its bag. The region was closely trailed by Europe which held over 35% in 2013 itself. Asia Pacific is likely to witness the leading growth among all the regions owing factors such as easy obtainability of medical services, enhanced medical infrastructure, and growing awareness among consumers. Europe and North America are likely to emerge as leading consumers of medical polymers. However, Asia Pacific is expected to snip shares from the developed economies.

Some of the top drawer companies operating in the global medical polymers market are Victrex plc., Formosa Plastics Corporation USA, The Dow Chemical Company, Evonik Industries AG, Eastman Chemical Company, and Celanese Corporation.

 
Chapter 1 Preface
1.1 Report description
1.2 Market segmentation
      1.2.1 Global medical polymers market segmentation
1.3 Research methodology
1.4 Research scope and assumptions
 
Chapter 2 Executive Summary
2.1 Global medical polymers market, 2013 – 2020 (Kilo Tons) (USD Million)
2.2 Medical polymers - Market snapshot (2013 and 2020)
 
Chapter 3 Medical Polymers – Industry Analysis
3.1 Introduction
3.2 Value chain analysis
      3.2.1 Medical polymers: Value chain analysis
3.3 Growth prospects for major polymers
3.4 Market drivers
      3.4.1 Increasing demand for medical devices to augment the medical polymer market growth
               3.4.1.1 Global medical devices market, 2013 – 2020 (USD Billion)
      3.4.2 Growing preference towards home healthcare treatment to boost demand for medical polymers
               3.4.2.1 Global medical disposables market, 2013 – 2020 (USD Billion)
      3.4.3 Aging population leading to increased demand for medical treatment
               3.4.3.1 Global population, by age group, 2010, 2015, and 2020
3.5 Market restraints
      3.5.1 Strict regulatory framework governing new product launches to restrain market growth
      3.5.2 Increasingly volatile raw material prices likely to impact the growth of the medical polymer market over the forecast period
               3.5.2.1 Global crude oil prices, January 2009 – August 2014 (USD per barrel)
3.6 Market opportunities
      3.6.1 Increasing importance of biodegradable materials in medical implants provides growth opportunities for medical polymers market
               3.6.1.1 Global medical implants market, 2013 – 2020 (USD Billion)
3.7 Porter’s five forces analysis
      3.7.1 Bargaining power of suppliers
      3.7.2 Bargaining power of buyers
      3.7.3 Threat from substitutes
      3.7.4 Degree of competition
3.8 Market attractiveness analysis
      3.8.1 Medical polymer: Market attractiveness analysis
 
Chapter 4 Global Medical Polymers Market – Product Segment Analysis
4.1 Global medical polymers market: Product overview
      4.1.1 Global medical polymers market volume share, by product, 2013 and 2020
4.2 Fibers and resins
      4.2.1 Global medical fibers and resins market volume share, by product, 2013 and 2020
      4.2.2 Polyvinyl chloride (PVC)
               4.2.2.1 Global PVC fibers and resins market for medical application, 2013 - 2020 (Kilo Tons) (USD Million)
      4.2.3 Polypropylene (PP)
               4.2.3.1 Global PP fibers and resins market for medical application, 2013 - 2020 (Kilo Tons) (USD Million)
      4.2.4 Polyethylene (PE)
              4.2.4.1 Global PE fibers and resins market for medical application, 2013 - 2020 (Kilo Tons) (USD Million)
      4.2.5 Polystyrene (PS)
              4.2.5.1 Global PS fibers and resins market for medical application, 2013 - 2020 (Kilo Tons) (USD Million)
      4.2.6 Others
              4.2.6.1 Global medical fibers and resins market for other polymers, 2013 - 2020 (Kilo Tons) (USD Million)
4.3 Medical elastomers
      4.3.1 Global medical elastomers market volume share, by product, 2013 and 2020
      4.3.2 Styrenic block copolymer (SBC)
               4.3.2.1 Global SBC market for medical applications, 2013 – 2020 (Kilo Tons) (USD Million)
      4.3.3 Rubber latex
               4.3.3.1 Global rubber latex market for medical applications, 2013 – 2020 (Kilo Tons) (USD Million)
      4.3.4 Others
               4.3.4.1 Global market for other polymers in medical applications, 2013 – 2020 (Kilo Tons) (USD Million)
4.4 Biodegradable plastics
      4.4.1 Global biodegradable plastics market for medical applications, 2013 – 2020 (Kilo Tons) (USD Million)
 
Chapter 5 Global Medical Polymers Market – Application Analysis
5.1 Global medical polymers market: Application overview
      5.1.1 Global medical polymers market volume share, by application, 2013 and 2020
5.2 Medical devices and equipment
      5.2.1 Global medical polymers market for medical devices and equipment, 2013 – 2020 (Kilo Tons) (USD Million)
5.3 Medical packaging
      5.3.1 Global medical polymers market for medical packaging, 2013 – 2020 (Kilo Tons) (USD Million)
5.4 Others
      5.4.1 Global medical polymers market for other medical applications, 2013 – 2020 (Kilo Tons) (USD Million)
 
Chapter 6 Global Medical Polymers Market – Regional Analysis
6.1 Global medical polymers market: Regional overview
      6.1.1 Global medical polymers market volume share, by region, 2013 and 2020
6.2 North America
      6.2.1 North America medical polymers market volume, by product, 2013 – 2020 (Kilo Tons)
      6.2.2 North America medical polymers market revenue, by product, 2013 – 2020 (USD Million)
      6.2.3 North America medical fibers and resins market volume, by product, 2013 – 2020 (Kilo Tons)
      6.2.4 North America medical fibers and resins market revenue, by product, 2013 – 2020 (USD Million)
      6.2.5 North America medical elastomers market volume, by product, 2013 – 2020 (Kilo Tons)
      6.2.6 North America medical elastomers market revenue, by product, 2013 – 2020 (USD Million)
      6.2.7 North America medical polymers market volume, by application, 2013 – 2020 (Kilo Tons)
      6.2.8 North America medical polymers market revenue, by application, 2013 – 2020 (USD Million)
6.3 Europe
      6.3.1 Europe medical polymers market volume, by product, 2013 – 2020 (Kilo Tons)
      6.3.2 Europe medical polymers market revenue, by product, 2013 – 2020 (USD Million)
      6.3.3 Europe medical fibers and resins market volume, by product, 2013 – 2020 (Kilo Tons)
      6.3.4 Europe medical fibers and resins market revenue, by product, 2013 – 2020 (USD Million)
      6.3.5 Europe medical elastomers market volume, by product, 2013 – 2020 (Kilo Tons)
      6.3.6 Europe medical elastomers market revenue, by product, 2013 – 2020 (USD Million)
      6.3.7 Europe medical polymers market volume, by application, 2013 – 2020 (Kilo Tons)
      6.3.8 Europe medical polymers market revenue, by application, 2013 – 2020 (USD Million)
6.4 Asia Pacific
      6.4.1 Asia Pacific medical polymers market volume, by product, 2013 – 2020 (Kilo Tons)
      6.4.2 Asia Pacific medical polymers market revenue, by product, 2013 – 2020 (USD Million)
      6.4.3 Asia Pacific medical fibers and resins market volume, by product, 2013 – 2020 (Kilo Tons)
      6.4.4 Asia Pacific medical fibers and resins market revenue, by product, 2013 – 2020 (USD Million)
      6.4.5 Asia Pacific medical elastomers market volume, by product, 2013 – 2020 (Kilo Tons)
      6.4.6 Asia Pacific medical elastomers market revenue, by product, 2013 – 2020 (USD Million)
      6.4.7 Asia Pacific medical polymers market volume, by application, 2013 – 2020 (Kilo Tons)
      6.4.8 Asia Pacific medical polymers market revenue, by application, 2013 – 2020 (USD Million)
6.5 Rest of the World (RoW)
      6.5.1 RoW medical polymers market volume, by product, 2013 – 2020 (Kilo Tons)
      6.5.2 RoW medical polymers market revenue, by product, 2013 – 2020 (USD Million)
      6.5.3 RoW medical fibers and resins market volume, by product, 2013 – 2020 (Kilo Tons)
      6.5.4 RoW medical fibers and resins market revenue, by product, 2013 – 2020 (USD Million)
      6.5.5 RoW medical elastomers market volume, by product, 2013 – 2020 (Kilo Tons)
      6.5.6 RoW medical elastomers market revenue, by product, 2013 – 2020 (USD Million)
      6.5.7 RoW medical polymers market volume, by application, 2013 – 2020 (Kilo Tons)
      6.5.8 RoW medical polymers market revenue, by application, 2013 – 2020 (USD Million)

Chapter 7 Company Profiles
7.1 BASF SE
      7.1.1 Company overview
      7.1.2 Product portfolio
      7.1.3 Financial overview
      7.1.4 Business strategies
      7.1.5 Recent developments
7.2 BayerMaterialScience AG
      7.2.1 Company overview
      7.2.2 Product portfolio
      7.2.3 Financial overview
      7.2.4 Business strategy
      7.2.5 Recent developments
7.3 Celanese Corporation
      7.3.1 Company overview
      7.3.2 Product portfolio
      7.3.3 Financial overview
      7.3.4 Business strategy
      7.3.5 Recent developments
7.4 DSM N.V.
      7.4.1 Company overview
      7.4.2 Product portfolio
      7.4.3 Financial overview
      7.4.4 Business strategy
      7.4.5 Recent developments
7.5 E. I. du Pont de Nemours Company
      7.5.1 Company overview
      7.5.2 Product portfolio
      7.5.3 Financial overview
      7.5.4 Business strategy
      7.5.5 Recent developments
7.6 Eastman Chemical Company
      7.6.1 Company overview
      7.6.2 Product portfolio
      7.6.3 Financial overview
      7.6.4 Business strategy
      7.6.5 Recent developments
7.7 Evonik Industries AG
      7.7.1 Company overview
      7.7.2 Product portfolio
      7.7.3 Financial overview
      7.7.4 Business strategy
      7.7.5 Recent developments
7.8 ExxonMobil Corporation
      7.8.1 Company overview
      7.8.2 Product portfolio
      7.8.3 Financial overview
      7.8.4 Business strategy
      7.8.5 Recent developments
7.9 The Dow Chemical Company
      7.9.1 Company overview
      7.9.2 Product portfolio
      7.9.3 Financial overview
      7.9.4 Business strategy
      7.9.5 Recent developments
7.10 Huizhou Foryou Medical Device Co., Ltd.
      7.10.1 Company overview
      7.10.2 Product portfolio
      7.10.3 Business strategy
      7.10.4 Recent developments
7.11 Kraton Performance Polymers, Inc.
      7.11.1 Company overview
      7.11.2 Product portfolio
      7.11.3 Financial overview
      7.11.4 Business strategy
      7.11.5 Recent developments
7.12 Tianjin Plastics Research Institute Co., Ltd.
      7.12.1 Company overview
      7.12.2 Product portfolio
      7.12.3 Business strategy
7.13 Formosa Plastics Corporation, U.S.A.
      7.13.1 Company overview
      7.13.2 Product portfolio
      7.13.3 Business strategy
      7.13.4 Recent developments
7.14 Shanghai New Shanghua Polymer Material Co., Ltd.
      7.14.1 Company overview
      7.14.2 Product portfolio
      7.14.3 Business strategy
7.15 Sinopec Beijing Yanshan Company
      7.15.1 Company overview
      7.15.2 Product portfolio
      7.15.3 Business strategy
      7.15.4 Recent development
7.16 Ningbo Yonghua Resin Co. Ltd.
      7.16.1 Company overview
      7.16.2 Product portfolio
      7.16.3 Business strategy
      7.16.4 Recent developments
7.17 SINOPEC Shanghai Petrochemical Co. Ltd.
      7.17.1 Company overview
      7.17.2 Product portfolio
      7.17.3 Financial overview
      7.17.4 Business strategy
      7.17.5 Recent developments
7.18 SABIC’s Innovative Plastics
      7.18.1 Company overview
      7.18.2 Product portfolio
      7.18.3 Business strategy
      7.18.4 Recent developments
7.19 Lubrizol Corporation
      7.19.1 Company overview
      7.19.2 Product portfolio
      7.19.3 Business strategy
      7.19.4 Recent developments
7.20 HBM Piaoan Medical Dressing. Inc
      7.20.1 Company overview
      7.20.2 Product portfolio
      7.20.3 Business strategy
      7.20.4 Recent developments
7.21 Victrex plc
      7.21.1 Company overview
      7.21.2 Product portfolio
      7.21.3 Financial overview
      7.21.4 Business strategy
      7.21.5 Recent developments
7.22 Huntsman Corporation
      7.22.1 Company overview
      7.22.2 Product portfolio
      7.22.3 Financial overview
      7.22.4 Business strategy
      7.22.5 Recent developments
7.23 China Haohua Chemical Group Co., Ltd.
      7.23.1 Company overview
      7.23.2 Business strategy
      7.23.3 Recent developments
7.24 INEOS
      7.24.1 Company overview
      7.24.2 Product portfolio
      7.24.3 Business strategy
      7.24.4 Recent developments
7.25 Jafron Biomedical Co., Ltd.
      7.25.1 Company overview
      7.25.2 Product portfolio
      7.25.3 Business strategy
      7.25.4 Recent developments
7.26 Solvay S.A.
      7.26.1 Company overview
      7.26.2 Product portfolio
      7.26.3 Financial overview
      7.26.4 Business strategy
      7.26.5 Recent developments
7.27 WEIGAO Holding Co., Ltd. (WEGO)
      7.27.1 Company overview
      7.27.2 Product portfolio
      7.27.3 Financial overview
      7.27.4 Business strategy
      7.27.5 Recent developments

List of Figures 
 
FIG. 1 Global medical polymers market segmentation
FIG. 2 Global medical polymers market, 2013 – 2020 (Kilo Tons) (USD Million)
FIG. 3 Medical polymers: Value chain analysis
FIG. 4 Global medical devices market, 2013 – 2020 (USD Billion)
FIG. 5 Global medical disposables market, 2013 – 2020 (USD Billion)
FIG. 6 Global population, by age group, 2010, 2015, and 2020
FIG. 7 Global crude oil prices, January 2009 – August 2014 (USD per barrel)
FIG. 8 Global medical implants market, 2013 – 2020 (USD Billion)
FIG. 9 Medical polymers: Porter’s five forces analysis
FIG. 10 Medical polymer: Market attractiveness analysis
FIG. 11 Global medical polymers market volume share, by product, 2013 and 2020
FIG. 12 Global medical fibers and resins market volume share, by product, 2013 and 2020
FIG. 13 Global PVC fibers and resins market for medical application, 2013 - 2020 (Kilo Tons) (USD Million)
FIG. 14 Global PP fibers and resins market for medical application, 2013 - 2020 (Kilo Tons) (USD Million)
FIG. 15 Global PE fibers and resins market for medical application, 2013 - 2020 (Kilo Tons) (USD Million)
FIG. 16 Global PS fibers and resins market for medical application, 2013 - 2020 (Kilo Tons) (USD Million)
FIG. 17 Global medical fibers and resins market for other polymers, 2013 - 2020 (Kilo Tons) (USD Million)
FIG. 18 Global medical elastomers market volume share, by product, 2013 and 2020
FIG. 19 Global SBC market for medical applications, 2013 – 2020 (Kilo Tons) (USD Million)
FIG. 20 Global rubber latex market for medical applications, 2013 – 2020 (Kilo Tons) (USD Million)
FIG. 21 Global market for other polymers in medical applications, 2013 – 2020 (Kilo Tons) (USD Million)
FIG. 22 Global biodegradable plastics market for medical applications, 2013 – 2020 (Kilo Tons) (USD Million)
FIG. 23 Global medical polymers market volume share, by application, 2013 and 2020
FIG. 24 Global medical polymers market for medical devices and equipment, 2013 – 2020 (Kilo Tons) (USD Million)
FIG. 25 Global medical polymers market for medical packaging, 2013 – 2020 (Kilo Tons) (USD Million)
FIG. 26 Global medical polymers market other medical applications, 2013 – 2020 (Kilo Tons) (USD Million)
FIG. 27 Global medical polymers market volume share, by region, 2013 and 2020

List of Tables 
 
TABLE 1 Medical polymers market: Global snapshot
TABLE 2 Market potential for medical polymers
TABLE 3 Drivers for medical polymer market: Impact analysis
TABLE 4 Restraints for medical polymers market: Impact analysis
TABLE 5 North America medical polymers market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 6 North America medical polymers market revenue, by product, 2013 – 2020 (USD Million)
TABLE 7 North America medical fibers and resins market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 8 North America medical fibers and resins market revenue, by product, 2013 – 2020 (USD Million)
TABLE 9 North America medical elastomers market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 10 North America medical elastomers market revenue, by product, 2013 – 2020 (USD Million)
TABLE 11 North America medical polymers market volume, by application, 2013 – 2020 (Kilo Tons)
TABLE 12 North America medical polymers market revenue, by application, 2013 – 2020 (USD Million)
TABLE 13 Europe medical polymers market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 14 Europe medical polymers market revenue, by product, 2013 – 2020 (USD Million)
TABLE 15 Europe medical fibers and resins market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 16 Europe medical fibers and resins market revenue, by product, 2013 – 2020 (USD Million)
TABLE 17 Europe medical elastomers market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 18 Europe medical elastomers market revenue, by product, 2013 – 2020 (USD Million)
TABLE 19 Europe medical polymers market volume, by application, 2013 – 2020 (Kilo Tons)
TABLE 20 Europe medical polymers market revenue, by application, 2013 – 2020 (USD Million)
TABLE 21 Asia Pacific medical polymers market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 22 Asia Pacific medical polymers market revenue, by product, 2013 – 2020 (USD Million)
TABLE 23 Asia Pacific medical fibers and resins market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 24 Asia Pacific medical fibers and resins market revenue, by product, 2013 – 2020 (USD Million)
TABLE 25 Asia Pacific medical elastomers market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 26 Asia Pacific medical elastomers market revenue, by product, 2013 – 2020 (USD Million)
TABLE 27 Asia Pacific medical polymers market volume, by application, 2013 – 2020 (Kilo Tons)
TABLE 28 Asia Pacific medical polymers market revenue, by application, 2013 – 2020 (USD Million)
TABLE 29 RoW medical polymers market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 30 RoW medical polymers market revenue, by product, 2013 – 2020 (USD Million)
TABLE 31 RoW medical fibers and resins market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 32 RoW medical fibers and resins market revenue, by product, 2013 – 2020 (USD Million)
TABLE 33 RoW medical elastomers market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 34 RoW medical elastomers market revenue, by product, 2013 – 2020 (USD Million)
TABLE 35 RoW medical polymers market volume, by application, 2013 – 2020 (Kilo Tons)
TABLE 36 RoW medical polymers market revenue, by application, 2013 – 2020 (USD Million)

The medical polymers market comprises resins and fibers, elastomers and biodegradable plastics that are used in various healthcare applications such as equipment and devices, packaging and tissue engineering. Polyvinyl chloride, polypropylene, polystyrene and polyethylene are the commonly used fibers and resins in the medical industry. Thermoplastic elastomers and rubber latex make up the elastomers segment of the medical polymers market. Biodegradable plastics such as PLA and PEEK are used increasingly due to stringent regulations by authorities such as the Food and Drug Administration (FDA). Growth in emerging economies of Asia Pacific in the medical polymers market is another important factor that is likely to boost product sales over the next few years. Medical polymers are used in the manufacture of devices and equipment in the medical & healthcare segment. Polymers such as polyethylene are used in medical packaging, while polyether ether ketone (PEEK) is used in tissue engineering. Demand for these materials is high in the medical polymers market.
 
The report on medical polymers market has been segmented into various chapters. Under each chapter, we have tackled a different aspect of the market and analyzed various parameters. Preface provides a brief diagrammatic representation on the segmentation of the medical polymers market. Additionally, the chapter offers a detailed description of the methodology used for research along with scope and assumptions used in estimating and analyzing the future market growth.
 
We have included an executive summary that includes a brief summary regarding the trends in the market. We have also included a snapshot of the market; it provides the current scenario as well as growth opportunities for the medical polymers market at the end of the forecast period. Throughout the report, 2013 has been considered as the base year with the forecast period ranging from 2014 to 2020.
 
Industry analysis provides an insight on the drivers and restraints of the medical polymers market and their impact on the growth of the market during the forecast period. Additionally, the study includes opportunities available in the market on a regional and global level and their effect during the forecast period. We have provided a detailed analysis of the value chain to help understand the medical polymers market better. Furthermore, a detailed analysis of Porter’s five forces model has been included to describe the intensity of competition in the market. Moreover, the study comprises a market attractiveness analysis, where applications are benchmarked based on market size, growth rate and general attractiveness. A detailed analysis of key players’ market share in the industry has been included to represent the nature of the market.
 
The medical polymers market has been segmented based on types of products, applications and geographies. All product segments have been analyzed and forecast based on volume (kilo tons) and revenue (USD million) for the period ranging from 2014 to 2020. Application segments have been analyzed and forecast based on current trends on the global and regional level from 2014 to 2020. Geographically, the market has been segmented into North America, Europe, Asia Pacific and Rest of the World. Analysis and forecast is based on current trends and ranges over a period from 2014 to 2020. 
 
Detailed profiles of leading companies are covered in the report along with an analysis of their market share. Leading companies in the market include BASF SE, Bayer MaterialScience AG, E. I. du Pont de Nemours Company, Eastman Chemical Company, The Dow Chemical Company, Kraton Performance Polymers Inc., Formosa Plastics Corporation, U.S.A., SABIC Innovative Plastics and Victrex Plc. Company profiles include attributes such as company overview, financial overview, business strategies and recent developments. 
 
The market has been segmented as below:
 
Medical Polymers Market - Product Segment Analysis
  • Medical resins and fibers
    • Polyvinyl chloride (PVC)
    • Polypropylene (PP)
    • Polyethylene (PE)
    • Polystyrene (PS)
    • Others (Including engineering thermoplastics such as ABS, PC and PET)
  • Medical elastomers
    • Styrenic block copolymer (SBC)
    • Rubber latex
    • Others (Including TPU, TPV and TPO)
  • Biodegradable plastics
Medical Polymers Market - Application Analysis
  • Medical devices and equipment
  • Medical packaging
  • Others (Including tissue engineering and cardio stents)
Medical Polymers Market - Regional Analysis
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW) 


 
 
Back To Top